标题
Pathology in drug discovery and development
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume 232, Issue 2, Pages 99-102
出版商
Wiley
发表日期
2013-10-12
DOI
10.1002/path.4290
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Developing biomarkers to predict benefit from HGF/MET pathway inhibitors
- (2013) Hartmut Koeppen et al. JOURNAL OF PATHOLOGY
- A matrix approach to guide IHC-based tissue biomarker development in oncology drug discovery
- (2013) Neil R Smith et al. JOURNAL OF PATHOLOGY
- Epistatic interactions and drug response
- (2013) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- The impact of germline mutations on targeted therapy
- (2013) Simon A Smith et al. JOURNAL OF PATHOLOGY
- Pathology is a necessary and informative tool in oncology clinical trials
- (2013) Iris D Nagtegaal et al. JOURNAL OF PATHOLOGY
- Implications of intratumour heterogeneity for treatment stratification
- (2013) Andrew Crockford et al. JOURNAL OF PATHOLOGY
- Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
- (2013) Jennifer Bates et al. JOURNAL OF PATHOLOGY
- Molecular pathology and prostate cancer therapeutics: from biology to bedside
- (2013) Daniel Nava Rodrigues et al. JOURNAL OF PATHOLOGY
- Somatic alterations as the basis for resistance to targeted therapies
- (2013) Brian G Blair et al. JOURNAL OF PATHOLOGY
- The genetic complexity of common cancers and the promise of personalized medicine: is there any hope?
- (2013) Monica Arnedos et al. JOURNAL OF PATHOLOGY
- Mouse tumour models to guide drug development and identify resistance mechanisms
- (2013) Meghna Das Thakur et al. JOURNAL OF PATHOLOGY
- The evolving genomic classification of lung cancer
- (2013) David S Shames et al. JOURNAL OF PATHOLOGY
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Using the molecular classification of glioblastoma to inform personalized treatment
- (2013) Adriana Olar et al. JOURNAL OF PATHOLOGY
- New drug targets in metastatic melanoma
- (2013) Blanca Homet et al. JOURNAL OF PATHOLOGY
- Mechanisms of age-related macular degeneration and therapeutic opportunities
- (2013) Menno van Lookeren Campagne et al. JOURNAL OF PATHOLOGY
- Biomarkers of drugs targeting HER-family signalling in cancer
- (2013) Filippo Montemurro et al. JOURNAL OF PATHOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and Use of Integral Assays in Clinical Trials
- (2012) R. L. Schilsky et al. CLINICAL CANCER RESEARCH
- Quality really matters: the need to improve specimen quality in biomedical research
- (2012) Daniel Simeon-Dubach et al. JOURNAL OF PATHOLOGY
- Foundation Medicine
- (2012) Michael Eisenstein NATURE BIOTECHNOLOGY
- Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer
- (2012) Tatiana M. Prowell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
- (2011) L. V. Sequist et al. ANNALS OF ONCOLOGY
- Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase
- (2011) Patricia J T A Groenen et al. HISTOPATHOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- A mouse model for EML4-ALK-positive lung cancer
- (2008) M. Soda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started